GlassScriptPhysician profile
Louai Razzouk
NPI 1477711984
$115,516.49
in general payments reported to CMS, 2019-2025
28 companies · $38K in 2025
The $38K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,303 · 2020: $13K · 2021: $2,881 · 2022: $4,523 · 2023: $28K · 2024: $23K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $15K · Consulting Fee: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,500.00 |
| Travel and Lodging | $15,417.01 |
| Consulting Fee | $15,150.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,750.00 |
| Food and Beverage | $12,898.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $34,590.90 | 2019-2025 | General - Vascular Access, Avvigo Guidance System, Rotapro |
| Shockwave Medical, INC | $32,145.96 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $21,685.29 | 2021-2025 | Ffrangio, Symplicity G3, In.Pact Admiral |
| Philips North America LLC | $13,470.47 | 2019-2024 | (P84) Igt Devices Systems |
| Abbott Laboratories | $2,254.11 | 2019-2025 | Optis, Dragonfly Opstar, Esprit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,000.00 | 2019 | |
| Csl Behring | $1,925.76 | 2021-2023 | |
| Abiomed | $1,891.42 | 2022-2025 | Impella |
| Zoll Circulation INC | $1,439.00 | 2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Penumbra, INC. | $1,333.07 | 2021 | |
| Cardiovascular Systems INC. | $556.05 | 2019-2022 | |
| Cathworks, INC. | $500.00 | 2024 | Ffrangio |
| Medtronic Vascular, INC. | $376.28 | 2019 | |
| Spectrawave, INC | $370.42 | 2023 | Hypervue Imaging System |
| Endologix LLC | $300.70 | 2025 | Torus Stent Graft System, Endocross Device |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.57 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $115.67 | 2022 | |
| Amgen INC. | $91.73 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $63.47 | 2024-2025 | |
| Asahi Intecc USA, INC. | $40.27 | 2025 | Asahi Coronary Wires |
| Cordis US Corp. | $37.69 | 2023 | Zephyr |
| Abbvie INC. | $27.78 | 2022 | |
| Cardinal Health 200 LLC | $23.27 | 2019 | |
| Recor Medical INC | $23.03 | 2025 | Paradise Ultrasound Renal Denervation System |
| Alnylam Pharmaceuticals INC. | $20.20 | 2019 | |
| Tanabe Pharma America, INC. | $19.52 | 2025 | Radicava |
| Beta Bionics, INC. | $17.86 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louai Razzouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.